Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Accumulated Expenses (2016 - 2018)

Historic Accumulated Expenses for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q3 2018 value amounting to $1.8 million.

  • Armata Pharmaceuticals' Accumulated Expenses rose 5292.58% to $1.8 million in Q3 2018 from the same period last year, while for Sep 2018 it was $1.8 million, marking a year-over-year increase of 5292.58%. This contributed to the annual value of $1.0 million for FY2017, which is 1731.84% up from last year.
  • According to the latest figures from Q3 2018, Armata Pharmaceuticals' Accumulated Expenses is $1.8 million, which was up 5292.58% from $1.4 million recorded in Q2 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Accumulated Expenses peaked at $1.8 million during Q3 2018, and registered a low of $10000.0 during Q3 2016.
  • Its 5-year average for Accumulated Expenses is $719294.1, with a median of $728000.0 in 2015.
  • In the last 5 years, Armata Pharmaceuticals' Accumulated Expenses plummeted by 9796.33% in 2016 and then soared by 1135000.0% in 2017.
  • Armata Pharmaceuticals' Accumulated Expenses (Quarter) stood at $457000.0 in 2014, then surged by 59.3% to $728000.0 in 2015, then rose by 22.94% to $895000.0 in 2016, then increased by 17.32% to $1.0 million in 2017, then surged by 66.76% to $1.8 million in 2018.
  • Its last three reported values are $1.8 million in Q3 2018, $1.4 million for Q2 2018, and $965000.0 during Q1 2018.